Donald Trump

Million

<ul class="wp-block-list">
 <li>Acurx Pharmaceuticals to invest $1M in bitcoin, citing its inflation-resistant and value-store qualities.&nbsp;&nbsp;</li>  
 <li>Biotech firms like Hoth and Enlivex join Acurx in adopting bitcoin as a treasury reserve strategy.&nbsp;&nbsp;</li>  
 <li>Institutional backing and bitcoin ETF approvals drive corporate adoption of cryptocurrency as a financial asset.&nbsp;&nbsp;</li> 
</ul>  
<p>Acurx Pharmaceuticals <a href="https://www.morningstar.com/news/pr-newswire/20241120ny61052/acurx-board-of-directors-approves-bitcoin-as-treasury-reserve-asset" rel="noopener noreferrer nofollow">announced</a> on Wednesday that its board of directors has given the green light to buy up to $1 million in bitcoin. The company plans to maintain the cryptocurrency as part of its treasury reserve asset. The news led to fluctuations in Acurx's stock, with an initial 8% increase during premarket trading followed by a more than 6% drop.</p>  
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter">
 <div class="wp-block-embed__wrapper">
  https://twitter.com/UPTRNDNEWS/status/1859462243965981065
 </div>
</figure>  
<p>David P. Luci, Acurx Pharmaceuticals' CEO, explained the decision in a press statement. He emphasized bitcoin's increasing popularity and recognition as a key asset class. He claimed that bitcoin's restricted quantity and inflation immunity make it a useful store of value.&nbsp;</p>  
<p>The new approach is primarily concerned with finances and has no bearing on the company's drug development goals. The new strategy focuses on finance and does not affect the company’s drug development plans.&nbsp;&nbsp;</p>  
<h2 class="wp-block-heading" id="h-bitcoin-gains-traction-among-corporates-nbsp-nbsp"><strong>Bitcoin Gains Traction Among Corporates&nbsp;&nbsp;</strong></h2>  
<p>Hoth Therapeutics, a biopharmaceutical company, has also <a href="https://www.prnewswire.com/news-releases/hoth-therapeutics-board-of-directors-approves-bitcoin-as-treasury-reserve-asset-302311213.html" rel="noopener noreferrer nofollow">approved</a> up to $1 million in bitcoin purchases. CEO Robb Kine highlighted how institutional investors now accept bitcoin and how regulations have recently improved. He emphasized that bitcoin is a reliable asset for treasury operations.&nbsp;&nbsp;</p>  
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter">
 <div class="wp-block-embed__wrapper">
  https://twitter.com/hataglobal/status/1859466168467386805
 </div>
</figure>  
<p>Enlivex Therapeutics followed a similar path, adding bitcoin to its financial strategy. The firm mentioned the cryptocurrency’s growing appeal and institutional backing as key factors.&nbsp;&nbsp;</p>  
<p>This method mirrors the one introduced by MicroStrategy, a business intelligence firm. MicroStrategy designated bitcoin as its primary reserve asset in 2020. The company now owns a total of <a href="https://cryptonewsland.com/microstrategys-bitcoin-strategy-draws-criticism-from-peter-schiff/" rel="noopener noreferrer nofollow">331,200 Bitcoins</a> after expanding its portfolio. MicroStrategy's stock has soared over 500% this year mostly driven by the unprecedented trading volumes of bitcoin.&nbsp;</p>  
<h2 class="wp-block-heading" id="h-broader-implications-for-bitcoin-nbsp-nbsp"><strong>Broader Implications for Bitcoin&nbsp;&nbsp;</strong></h2>  
<p>The use of Bitcoin as a corporate treasury asset is still growing, although it is still happening gradually. Analysts predict that adoption rates will increase as President-elect Donald Trump creates a more crypto-friendly regulatory environment.&nbsp;</p>  
<p>Institutional interest has also broadened to the government level. Senator Cynthia Lummis <a href="https://cryptonewsland.com/senator-cynthia-lummis-urges-u-s-to-consider-bitcoin-reserves-for-dollar-stability/" rel="noopener noreferrer nofollow">proposed a national bitcoin reserve</a>, while Trump hinted at a potential federal reserve. With bitcoin ETFs gaining approval and increasing corporate adoption, investors are watching for the next major players to join this trend.</p> 
<p>The post <a href="https://cryptonewsland.com/acurx-pharmaceuticals-approves-1-million-bitcoin/" rel="noopener noreferrer nofollow">Acurx Pharmaceuticals Approves $1 Million Bitcoin Purchase for Treasury Strategy</a> appeared first on <a href="https://cryptonewsland.com" rel="noopener noreferrer nofollow">Crypto News Land</a>.</p>

Acurx Pharmaceuticals Approves $1 Million Bitcoin Purchase for Treasury Strategy

Table of Contents

Crypto News Land

Other articles published on Nov 21, 2024

FTX Sues Binance and CEO Changpeng Zhao for $1.8B Over Alleged Fraud

Bybit Launches Gold & FX Treasure Hunt Competition: Embark on a Quest for Real Gold Rewards

Coinbase Wallet Launches 4.7% APY Incentive for USDC Holders

Bitcoin Market Cap Approaches $2 Trillion, Targets Amazon and Alphabet

Bitcoin hit $95,000: heading to $100k target price

Trump’s Team in Talks with Crypto Leaders for Major Regulatory Shift: Report

Join our free newsletter for daily crypto updates!